References
[1] Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, et al . Editor’s Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2018; 55: 3-81.
[2] Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis. 1991; 325: 445-53.
[3] Warlow C. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. The Lancet. 1991; 337: 1235-43.
[4] Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J,et al . Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004; 363: 1491-502.
[5] Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, et al . Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arteriosclerosis, thrombosis, and vascular biology. 2009; 29: 128-33.
[6] Redgrave JN, Gallagher P, Lovett JK, Rothwell PM. Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke. 2008; 39: 1722-9.
[7] Olejarz W, Lacheta D, Kubiak-Tomaszewska G. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability. International journal of molecular sciences. 2020; 21 (11).
[8] Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR,et al . Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke. 2000; 31: 40-7.
[9] Loftus IM, Naylor AR, Bell PR, Thompson MM. Matrix metalloproteinases and atherosclerotic plaque instability. The British journal of surgery. 2002; 89: 680-94.
[10] Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis. 2010; 213: 21-9.
[11] Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American Heart Journal. 2001; 141: 211-7.
[12] Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al . Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. Journal of the American College of Cardiology. 1998; 32: 368-72.
[13] Tang QD, Wu PS, Hou YQ, Huang Z, Zhou ZJ, Guo ZG, et al . [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2009; 29: 1004-7.
[14] Loftus IM, Naylor AR, Bell PR, Thompson MM. Plasma MMP-9 - a marker of carotid plaque instability. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2001; 21: 17-21.
[15] Baroncini LA, Filho Pazin A, Murta LO, Jr., Nakao LS, Ramos SG, Precoma DB. Videodensitometric analysis of advanced carotid plaque: correlation with MMP-9 and TIMP-1 expression. Cardiovascular Ultrasound. 2011; 9: 24.
[16] Baroncini VLA, Nakao LS, Ramos SG, Filho AP, Murta LO, Jr., Ingberman M, et al . Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques. Thrombosis journal.. 2011; 9: 6.
[17] Oates CP, Naylor AR, Hartshorne T, Charles SM, Fail T, Humphries K, et al . Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2009; 37: 251-61.
[18] Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, et al . Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013; 44: 3071-7.
[19] Millon A, Mathevet JL, Boussel L, Faries PL, Fayad ZA, Douek PC, et al . High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques. Journal of Vascular Surgery. 2013; 57: 1046-51 e2.
[20] Saito H, Kuroda S, Hirata K, Magota K, Shiga T, Tamaki N,et al . Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Cerebrovascular diseases (Basel, Switzerland). 2013; 35: 370-7.
[21] Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al . Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health technology assessment. 2006; 10:iii-iv, ix-x, 1-182.
[22] Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al . In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001; 104: 2051-6.
[23] Jiang XB, Yuan WS, Wang JS, Liu Z, Liu DH, Shi ZS. Matrix metalloproteinase-9 expression in carotid atherosclerotic plaque and contrast-enhanced MRI in a swine model. Journal of neurointerventional surgery. 2014; 6: 24-8.
[24] World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013; 310: 2191-4.
[25] Moneta GL, Edwards JM, Chitwood RW, Taylor LM, Jr., Lee RW, Cummings CA, et al. Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. Journal of Vascular Surgery. 1993; 17: 152-7; discussion 7-9.
[26] Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351: 1379-87.
[27] Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273: 1421-8.
[28] Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002; 106: 1368-73.
[29] Sef D, Skopljanac-Macina A, Milosevic M, Skrtic A, Vidjak V. Cerebral Neuromonitoring during Carotid Endarterectomy and Impact of Contralateral Internal Carotid Occlusion. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2018; 27: 1395-402.
[30] Verhoeven BA, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. European journal of epidemiology. 2004; 19: 1127-33.
[31] Hellings WE, Moll FL, de Vries JP, de Bruin P, de Kleijn DP, Pasterkamp G. Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation: a cohort study. Stroke. 2008; 39: 1029-32.
[32] Derksen WJ, Peeters W, van Lammeren GW, Tersteeg C, de Vries JP, de Kleijn DP, et al . Different stages of intraplaque hemorrhage are associated with different plaque phenotypes: a large histopathological study in 794 carotid and 276 femoral endarterectomy specimens. Atherosclerosis. 2011; 218: 369-77.
[33] Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, et al . Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. The Journal of clinical investigation. 1990; 86: 1496-502.
[34] de Nooijer R, Verkleij CJ, von der Thusen JH, Jukema JW, van der Wall EE, van Berkel TJ, et al . Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arteriosclerosis, thrombosis, and vascular biology. 2006; 26: 340-6.
[35] Altaf N, Akwei S, Auer DP, MacSweeney ST, Lowe J. Magnetic resonance detected carotid plaque hemorrhage is associated with inflammatory features in symptomatic carotid plaques. Annals of vascular surgery. 2013; 27: 655-61.
[36] Arai D, Yamaguchi S, Murakami M, Nakakuki T, Fukuda S, Satoh-Asahara N, et al . Characteristics of carotid plaque findings on ultrasonography and black blood magnetic resonance imaging in comparison with pathological findings. Acta neurochirurgica. Supplement. 2011; 112: 15-9.
[37] Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, et al . Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation. 2001; 104: 921-7.
[38] Heo SH, Cho CH, Kim HO, Jo YH, Yoon KS, Lee JH, et al . Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. Journal of clinical neurology (Seoul, Korea). 2011; 7: 69-76.
[39] Cappendijk VC, Heeneman S, Kessels AG, Cleutjens KB, Schurink GW, Welten RJ, et al . Comparison of single-sequence T1w TFE MRI with multisequence MRI for the quantification of lipid-rich necrotic core in atherosclerotic plaque. Journal of magnetic resonance imaging : Journal of magnetic resonance imaging : JMRI. 2008; 27: 1347-55.